Ascendis Pharma A/S Losses On Change In Fair Value Of Derivatives
Ascendis Pharma A/S (ASND) reported Losses On Change In Fair Value Of Derivatives of EUR 15.48 million for the 12-month period ending 2022-12-31, per its 20-F filed 2024-02-07.
Discontinued › Notes
ifrs-full:LossesOnChangeInFairValueOfDerivatives · last filed 2024-02-07
| Period end | Losses On Change In Fair Value Of Derivatives 12 month |
|---|---|
| 2022-12-31 | 15.48M EUR 20-F · filed 2024-02-07 |